Introduction: IgG4 disease is an orphan, fibro-inflammatory autoimmune disease of recent discovery whose thoracic involvement is rarer. We report a case of Pulmonary and orbital bifocal IgG4 disease with a review of the literature. Observation: This is a 71-year-old patient with a history of hypertension, dyslipidemia, smoking cessation at 15 PA, with progressive dyspnoea, weight loss of 4 kg with PS = 0 for 2 months. The thoracic CT scan revealed 3 pseudotumoral lung lesions of the LIG, LID and LM. The histology of the two CT-guided lung biopsies and the LIG wedge had objectified inflammatory lesions without signs of malignancy. The evolution was marked by the occurrence of a right orbital edema. The cerebral scanner found a voluminous right orbital inflammatory pseudotumor. Biopsy with histology found fibroinflammatory lesions with lymphoplasmacytic infiltrates and positive immunolabeling with anti-IgG4 antibodies. The PET scanner had objectified pulmonary and pleural parenchymal consolidations and moderately hypermetabolic mediastinal ADP with max SUV between 3 and 6. The patient was put on corticosteroid therapy with a favorable outcome. Conclusion: IgG4 disease is rare and difficult to diagnose despite well-defined and consensual diagnostic criteria and classification. The discovery of new biomarkers facilitates the diagnosis and monitoring of patients. Well-codified corticosteroid therapy is effective but possibility of recurrence. The current challenge remains the lack of data on the follow-up of these patients to assess the risk of neoplasia (lymphoma).
References
[1]
Schleinitz, N., Briantais, A. and Ebbo, M. (2020) IgG4-Related Disease: Diagnostic Criteria Evolution toward the 2019 ACR/EULAR Classification Criteria. La Revue de Médecine Interne,41, 814-821. https://doi.org/10.1016/j.revmed.2020.06.015
[2]
Chen, Y., Cai, S., Dong, L. and Umehara, H. (2022) Update on Classification, Diagnosis, and Management of Immunoglobulin G4-Related Disease. Chinese Medical Journal, 135, 381-392. https://doi.org/10.1097/CM9.0000000000001891
[3]
Yamada, K., Yamamoto, M., Saeki, T., Mizushima, I., Matsui, S., Fujisawa, Y., et al. (2017) New Clues to the Nature of Immunoglobulin G4-Related Disease: A Retrospective Japanese Multicenter Study of Baseline Clinical Features of 334 Cases. Arthritis Research & Therapy, 19, 262. https://doi.org/10.1186/s13075-017-1467-x
[4]
Yi, E.S., Sekiguchi, H., Peikert, T., et al. (2012) Pathologic Manifestations of IgG4-Related Lung Disease. Seminars in Diagnostic Pathology, 29, 219-225. https://doi.org/10.1053/j.semdp.2012.07.002
[5]
Berrier, A., Gomez, E., Essari, L.-A., Soler, J., Petit, I., Pierre, C., et al. (2021) La maladie associée aux IgG4: Une cause rare de pneumopathie infiltrante hypoxémiante sévère. Revue des Maladies Respiratoires, 38, 530-534. https://doi.org/10.1016/j.rmr.2021.02.071
[6]
Ryu, J.H., Sekiguchi, H. and Yi, E.S. (2012) Pulmonary Manifestations of Immunoglobulin G4-Related Sclerosing Disease. European Respiratory Journal, 39, 180-186. https://doi.org/10.1183/09031936.00025211
[7]
Zhou, Y., Shao, L., Ruan, W., Jin, J., Xu, H., Ying, K., et al. (2019) Pulmonary Vascular Involvement of IgG4-Related Disease: Case Series with a PRISMA-Compliant Systemic Review. Medicine (Baltimore), 98, e14437. https://doi.org/10.1097/MD.0000000000014437
[8]
Müller, R., Habert, P., Ebbo, M., Graveleau, J., Groh, M., Launay, D., Audia, S., et al. (2020) L’atteinte thoracique est fréquente au cours de la maladie associée aux IgG4: Étude multicentrique rétrospective. La Revue de Médecine Interne, 41, 27-28. https://doi.org/10.1016/j.revmed.2020.10.052
[9]
Wallace, Z.S., Naden, R.P., Chari, S., et al. (2020) The 2019 American College of Rheumatology/European League against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis & Rheumatology, 72, 7-19.
[10]
Deshpande, V., Zen, Y., Chan, K.J., Yi, E.E., Sato, Y., Yoshino, T., et al. (2012) Consensus Statement on the Pathology of IgG4-Related Disease. Modern Pathology, 25, 1181-1192. https://doi.org/10.1038/modpathol.2012.72
[11]
Tang, J., Cai, S., Ye, C. and Dong, L. (2020) Biomarkers in IgG4-Related Disease: A Systematic Review. Seminars in Arthritis and Rheumatism, 50, 354-359. https://doi.org/10.1016/j.semarthrit.2019.06.018
[12]
Takanashi, S., Kikuchi, J., Sasaki, T., Akiyama, M., Yasuoka, H., Yoshimoto, K., et al. (2021) Lymphadenopathy in IgG4-Related Disease: A Phenotype of Severe Activity and Poor Prognosis, with Eotaxin-3 as a New Biomarker. Rheumatology (Oxford), 60, 967-975. https://doi.org/10.1093/rheumatology/keaa648
[13]
Ebbo, M., Grados, A., et al. (2012) Maladie systemique associee aux IgG4: Une pathologie emergente? Mise au point et revue de la litterature. La Revue de Médecine Interne, 33, 23-34. https://doi.org/10.1016/j.revmed.2011.08.012
[14]
Bennis, R., Roy, T., Atto, Y.N. and Colin, M.I. (2020) La maladie systémique à IgG4, une cause rare de pancréatite aigüe sévère. Louvain Médical, 139, 185-191.
[15]
Pellet, L., Coattrenec, Y., Moll, S. and Seebach, J.D. (2019) Maladie à IgG4: L’expérience genevoise. Revue Médicale Suisse, 15, 736-741. https://doi.org/10.53738/REVMED.2019.15.645.0736
[16]
Umehara, H., Okazaki, K., Kawa, S., Takahashi, H., Goto, H., Matsui, S., et al. (2021) The 2020 Revised Comprehensive Diagnostic (RCD) Criteria for IgG4-RD. Modern Rheumatology, 31, 529-533.
[17]
Matsui, S., Yamamoto, H., Minamoto, S., Waseda, Y., Mishima, M. and Kubo, K. (2016) Proposed Diagnostic Criteria for IgG4-Related Respiratory Disease. Respiratory Investigation, 54, 130-132. https://doi.org/10.1016/j.resinv.2015.09.002
[18]
Okazaki, K., Chari, S.T., Frulloni, L., Lerch, M.M., Kamisawa, T., Kawa, S., et al. (2017) International Consensus for the Treatment of Autoimmune Pancreatitis. Pancreatology, 17, 1-6. https://doi.org/10.1016/j.pan.2016.12.003
[19]
Khosroshahi, A. and Stone, J.H. (2011) Treatment Approaches to IgG4-Related Systemic Disease. Current Opinion in Rheumatology, 23, 67-71. https://doi.org/10.1097/BOR.0b013e328341a240
[20]
Delteil, C., Chesnaisa, A.-L., Tasei, A.-M., Cohen-Pansieri, C., Naffaa, N. and Granier, G. (2016) Maladie à immunoglobuline G4 pulmonaire: Rapport de cas et revue de littérature. Annales de Pathologie, 36, 218-221. https://doi.org/10.1016/j.annpat.2016.02.001